Roelofsen H, Müller M, Jansen P L
Department of Internal Medicine, University Hospital, Groningen, The Netherlands.
Yale J Biol Med. 1997 Jul-Aug;70(4):435-45.
In several liver diseases the biliary transport is disturbed, resulting in, for example, jaundice and cholestasis. Many of these symptoms can be attributed to altered regulation of hepatic transporters. Organic anion transport, mediated by the canalicular multispecific organic anion transporter (cmoat), has been extensively studied. The regulation of intracellular vesicular sorting of cmoat by protein kinase C and protein kinase A, and the regulation of cmoat-mediated transport in endotoxemic liver disease, have been examined. The discovery that the multidrug resistance protein (MRP), responsible for multidrug resistance in cancers, transports similar substrates as cmoat led to the cloning of a MRP homologue from rat liver, named mrp2. Mrp2 turned out to be identical to cmoat. At present there is evidence that at least two mrp's are present in hepatocytes, the original mrp (mrp1) on the lateral membrane, and mrp2 (cmoat) on the canalicular membrane. The expression of mrp1 and mrp2 in hepatocytes appears to be cell-cycle-dependent and regulated in a reciprocal fashion. These findings show that biliary transport of organic anions and possibly other canalicular transport is influenced by the entry of hepatocytes into the cell cycle. The cloning of the gene for cmoat opens up new possibilities to study the regulation of hepatic organic anion transport.
在几种肝脏疾病中,胆汁转运受到干扰,例如导致黄疸和胆汁淤积。这些症状中的许多都可归因于肝脏转运体调节的改变。由胆小管多特异性有机阴离子转运体(cmoat)介导的有机阴离子转运已得到广泛研究。已经研究了蛋白激酶C和蛋白激酶A对cmoat细胞内囊泡分选的调节,以及内毒素血症性肝病中cmoat介导的转运调节。负责癌症多药耐药性的多药耐药蛋白(MRP)转运与cmoat相似底物这一发现,导致从大鼠肝脏克隆出一个MRP同源物,命名为mrp2。结果发现mrp2与cmoat相同。目前有证据表明,肝细胞中至少存在两种MRP,一种是位于侧膜的原始MRP(mrp1),另一种是位于胆小管膜的mrp2(cmoat)。mrp1和mrp2在肝细胞中的表达似乎依赖于细胞周期,并以相互的方式受到调节。这些发现表明,有机阴离子的胆汁转运以及可能的其他胆小管转运受肝细胞进入细胞周期的影响。cmoat基因的克隆为研究肝脏有机阴离子转运的调节开辟了新的可能性。